A Study of LY01008 and Bevacizumab Combined With Paclitaxel and Carboplatin for Treatment of Naïve Subjects With Metastatic or Recurrent Nonsquamous Non-small Cell Lung Cancer
Clinical trial NCT03533127 · UNKNOWN
Trial details
- NCT number
- NCT03533127
- Sponsor
- Luye Pharma Group Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-27
- Primary completion
- 2020-06-28
- Enrollment
- 648
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.